Re: Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986

Samir S. Taneja

    Research output: Contribution to journalComment/debatepeer-review

    Original languageEnglish (US)
    Pages (from-to)1585-1586
    Number of pages2
    JournalJournal of Urology
    Volume187
    Issue number5
    DOIs
    StatePublished - May 2012

    ASJC Scopus subject areas

    • Urology

    Cite this